These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
978 related items for PubMed ID: 18624987
1. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S, Rubaltelli FF. Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987 [Abstract] [Full Text] [Related]
2. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076 [Abstract] [Full Text] [Related]
3. Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Arch Dis Child Fetal Neonatal Ed; 2008 Mar; 93(2):F94-9. PubMed ID: 17768157 [Abstract] [Full Text] [Related]
4. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, Rubaltelli FF. Acta Paediatr; 2000 Nov; 89(11):1369-74. PubMed ID: 11106052 [Abstract] [Full Text] [Related]
7. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus. Pacifici GM. Curr Pediatr Rev; 2014 Nov; 10(3):216-37. PubMed ID: 25088343 [Abstract] [Full Text] [Related]
8. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Chotigeat U, Jirapapa K, Layangkool T. J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149 [Abstract] [Full Text] [Related]
11. The Effect of Oral High-dose Ibuprofen on Patent Ductus Arteriosus Closure in Preterm Infants. Pourarian S, Takmil F, Cheriki S, Amoozgar H. Am J Perinatol; 2015 Oct; 32(12):1158-63. PubMed ID: 26007314 [Abstract] [Full Text] [Related]
12. Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention? Dani C, Mosca F, Cresi F, Lago P, Lista G, Laforgia N, Del Vecchio A, Corvaglia L, Paolillo P, Trevisanuto D, Capasso L, Fanos V, Maffei G, Boni L. Early Hum Dev; 2019 Aug; 135():16-22. PubMed ID: 31212222 [Abstract] [Full Text] [Related]
17. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Richards J, Johnson A, Fox G, Campbell M. Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568 [Abstract] [Full Text] [Related]
18. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S. Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541 [Abstract] [Full Text] [Related]
19. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants]. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Med Wieku Rozwoj; 2005 May; 9(3 Pt 1):335-54. PubMed ID: 16547381 [Abstract] [Full Text] [Related]